Drug Pipeline

Zelenectide pevedotin Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
0
Recruiting
1
Top Sponsors
6
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-05-28 NCT06225596
Study BT8009-230 in Participants With Locally Advanced or Metastatic Urothelial Cancer…		 Phase changed: ['PHASE2', 'PHASE3'] -> ['PHASE2']
2026-05-28 NCT06225596
Study BT8009-230 in Participants With Locally Advanced or Metastatic Urothelial Cancer…		 Primary endpoint(s) modified
2026-05-28 NCT06225596
Study BT8009-230 in Participants With Locally Advanced or Metastatic Urothelial Cancer…		 Enrollment reduced: 956 -> 375 participants
2026-05-28 NCT06225596
Study BT8009-230 in Participants With Locally Advanced or Metastatic Urothelial Cancer…		 Trial arms changed: 6 -> 5
2026-05-28 NCT06225596
Study BT8009-230 in Participants With Locally Advanced or Metastatic Urothelial Cancer…		 date change Primary completion moved earlier: 2030-12 -> 2028-03
2026-05-28 NCT06225596
Study BT8009-230 in Participants With Locally Advanced or Metastatic Urothelial Cancer…		 date change Completion moved earlier: 2030-12 -> 2028-03
Active Studies by Phase
Phase 2
3
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT06840483 Study of Zelenectide Pevedotin in Participants With Advanced Breast Cancer Breast Cancer Active, Not Recruiting
NCT06933329 Zelenectide Pevedotin in NECTIN4 Amplified Advanced or Metastatic Non-small Cell Lung… Non-Small Cell Lung Cancer Active, Not Recruiting
NCT06225596 Study BT8009-230 in Participants With Locally Advanced or Metastatic Urothelial Cancer… Metastatic Urothelial Cancer Active, Not Recruiting
Sponsors Running Zelenectide pevedotin Trials
BicycleTx Limited (3)
Disease Areas
Breast Cancer (1) Non-Small Cell Lung Cancer (NSCLC) (1) Lung Cancer (1)
Get alerts when Zelenectide pevedotin trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free